Biopharmaceutical Segment Dominating the Biotechnology Industry in India
Fast growing biosimilar market and rising diagnostics business is expected to enable Biopharma industry to grow at 24% CAGR by 2014, says RNCOS.

The study has identified that biopharmaceutical is currently the most dominant market segment. The segment growth has largely been benefitted by Government policies and regulations and developed in-house capability to manufacture innovative biopharma products. It is anticipated that India has the capabilities and requisite talent to become a major supplier of biogeneric to the developed world in the coming years that will drive the market growth to achieve new heights.
Further, as the Indian pharmaceutical and biotech companies are raising their R&D spending and expanding manufacturing capacities, the life sciences suppliers market is also growing in-line with the biotechnology industry. India represents one of the fastest growing regions for leading global suppliers.
Our report, "Booming Biotech Market in India", has been authored to evaluate the future market potentials of the Indian Biotech industry and its segments. It provides extensive research and analysis of the overall market and all prominent segments including biopharmaceuticals, bioservices, bioagriculture, bioinformatics, and industrial biotechnology. Besides providing information on current market developments and market trends, the report also provides segment-wise forecasts based on correlation of past drivers, challenges, and opportunities for expansion, thus enabling clients to access projected market trends and take informed decisions.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM110.htm
Some of our Related Reports are:
- Global Gene Therapy Market Analysis
- Global Protein Therapeutics Market Analysis
- Global Biosimilars Market Analysis
- Asia Pacific Biotechnology Market (2008-2012)
- Israel Life Sciences Market Analysis
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
About RNCOS
RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, along with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.
###
Tag Words:
india biotech industry
Categories: Health
Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707